Logo

American Heart Association

  2
  0


Final ID:

DEBATE (CON REBUTTAL): We can work it out: Deprescribing sends the wrong message & should be discouraged

  • Hernandez, Adrian  ( Duke Clinical Research Institute , Durham , North Carolina , United States )
  • Morris, Alanna  ( EMORY UNIVERSITY SCHOOL MEDICINE , Atlanta , Georgia , United States )
  • Fonarow, Gregg  ( UCLA MEDICAL CENTER , Los Angeles , California , United States )
  • Author Disclosures:
    Adrian Hernandez: DO have relevant financial relationships ; Researcher:AstraZeneca:Active (exists now) ; Researcher:Verve:Active (exists now) ; Researcher:Intellia:Active (exists now) ; Researcher:NovoNordisk:Active (exists now) ; Researcher:Merck:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:Cytokinetics:Active (exists now) ; Researcher:Amgen:Active (exists now) ; Researcher:Boehringer Ingelheim:Active (exists now) ; Researcher:Bayer:Active (exists now) | Alanna Morris: No Answer | Gregg Fonarow: DO have relevant financial relationships ; Consultant:Abbott:Past (completed) ; Consultant:Johnson and Johnson:Past (completed) ; Consultant:Pfizer:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Eli Lilly:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:Amgen:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
All you need is less?

Schwartz Janice

I Get By with a Little Help from my Pharmacist: Evidence-based strategies for deprescribing in patients with cardiovascular disease

Gray Shelly, Zullo Andrew, Birtcher Kim, Krishnaswami Ashok, Carey Jessica, Cornelio Cyrille

You have to be authorized to contact abstract author. Please, Login
Not Available